|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Cash at Federal Reserve and other banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities: | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Trading securities | ||||||||||||||||||||
| Available for sale debt securities, at fair value (amortized cost of $1,857,352 and $1,883,412) | ||||||||||||||||||||
| Held to maturity debt securities, at amortized cost, net of allowance for credit losses of $0 | ||||||||||||||||||||
| Restricted equity securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Cash value of life insurance | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Operating leases, right-of-use | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing demand | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Junior subordinated debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value: 1,000,000 shares authorized, zero issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, no par value: 50,000,000 shares authorized; 31,965,507 and 32,334,974 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity |
Loading...
